Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 429–429 | Cite as

Retapamulin

Application site oedema: case report
Case report
  • 7 Downloads

Reference

  1. Hong W, et al. An open label, multi-center, non-interventional post-marketing surveillance to monitor the safety and efficacy of ALTARGO (retapamulin) administered in Korean patients according to the prescribing information. Annals of Dermatology 30: 441-450, No. 4, Aug 2018. Available from: URL: http://doi.org/10.5021/ad.2018.30.4.441 - South KoreaCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations